Not applicableEnded earlyNCT01954576What this trial is testingNovoTTF Therapy in Treating Patients With Recurrent Glioblastoma MultiformeWho this might be right forGlioblastomaBrain Neoplasms University of Florida 21
Early research (Phase 1)WithdrawnNCT00458744What this trial is testingTalotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWho this might be right forBrain and Central Nervous System TumorsLeukemiaLymphoma+1 more Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01239316What this trial is testingVismodegib in Treating Younger Patients With Recurrent or Refractory MedulloblastomaWho this might be right forRecurrent Childhood Medulloblastoma National Cancer Institute (NCI) 12
Not applicableWithdrawnNCT03636958What this trial is testingEfficacy and Safety of Perampanel in Combination in Glioma-refractory EpilepsyWho this might be right forRefractory Epilepsy Assistance Publique Hopitaux De Marseille
Testing effectiveness (Phase 2)Ended earlyNCT01836549What this trial is testingImetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic EpendymomaAstrocytoma, Grade II+6 more Pediatric Brain Tumor Consortium 43
Testing effectiveness (Phase 2)Ended earlyNCT00014443What this trial is testingTopotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Rush University Medical Center 5
Early research (Phase 1)Temporarily pausedNCT06355908What this trial is testingIL13Rα2 CAR-T for Patients With r/r GliomaWho this might be right forGlioma Yang Zhang 30
Early research (Phase 1)Ended earlyNCT07121829What this trial is testingTovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsWho this might be right forMelanomaSolid TumorPilocytic Astrocytoma+7 more Day One Biopharmaceuticals, Inc. 44
Early research (Phase 1)Ended earlyNCT05429502What this trial is testingStudy of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid TumorsWho this might be right forNeuroblastoma Novartis Pharmaceuticals 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05540275What this trial is testingTislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma Henan Provincial People's Hospital 30
Testing effectiveness (Phase 2)UnknownNCT02839954What this trial is testingCAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid TumorWho this might be right forHepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Large-scale testing (Phase 3)Ended earlyNCT03149575What this trial is testingVAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBMWho this might be right forGlioblastoma MultiformeGlioblastomaGlioma+2 more DelMar Pharmaceuticals, Inc. 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652What this trial is testingEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT02626364What this trial is testingStudy of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene AmplificationWho this might be right forRecurrent/Refractory Glioblastoma Arog Pharmaceuticals, Inc. 11
Not applicableLooking for participantsNCT07242963What this trial is testingRelapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry StudyWho this might be right forMedulloblastoma RecurrentMedulloblastoma, Childhood, RecurrentMedulloblastoma, SHH-activated and TP53 Mutant+1 more Mohammad H. Abu Arja 300
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Active Not RecruitingNCT03389802What this trial is testingPhase I Study of APX005M in Pediatric Central Nervous System TumorsWho this might be right forGlioblastoma MultiformeHigh-grade Astrocytoma Not Otherwise Specified (NOS)CNS Primary Tumor, Not Otherwise Specified (NOS)+3 more Pediatric Brain Tumor Consortium 32
Early research (Phase 1)Ended earlyNCT02255461What this trial is testingPalbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsWho this might be right forChildhood Choroid Plexus TumorChildhood EpendymoblastomaChildhood Grade III Meningioma+16 more Pediatric Brain Tumor Consortium 35
Testing effectiveness (Phase 2)Study completedNCT04773782What this trial is testingAvapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA SignalingWho this might be right forSolid Tumor, Unspecified, ChildRelapsed Solid NeoplasmCNS Tumor Blueprint Medicines Corporation 29
Early research (Phase 1)Study completedNCT00098761What this trial is testingVNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Pediatric Brain Tumor Consortium 42